[1]
“Safety Profile of 5% Albumin Versus Fresh Frozen Plasma in Therapeutic Plasma Exchange for Guillain-Barré Syndrome”, Planet (Barisal), vol. 9, no. 2, pp. 9–13, Mar. 2026, Accessed: Apr. 20, 2026. [Online]. Available: https://bdjournals.org/planet/article/view/1024